As with any surgical implantation procedure involving active neuromodulation devices, the use of Barostim carries potential risks and procedure-related side effects. Common risks include localized surgical site complications such as pain, bruising, swelling, inflammation, or infection around the pulse generator pocket and the lead insertion area. Additional potential risks associated with nerve stimulation or the procedure itself include temporary nerve injury, muscle discomfort, transient changes in blood pressure or heart rate, device migration, or technical malfunctions requiring subsequent revision surgeries. Patients are carefully evaluated by cardiology teams to weigh these procedural risks against potential clinical benefits.